Persistent Fever and Positive PCR 90 Days Post-SARS-CoV-2 Infection in a Rituximab-Treated Patient: A Case of Late Antiviral Treatment

Persistent Fever and Positive PCR 90 Days Post-SARS-CoV-2 Infection in a Rituximab-Treated Patient: A Case of Late Antiviral Treatment

<b>Background:</b> Persistent fever after SARS-CoV-2 infection in rituximab-treated patients has been reported. Due to reduced sensitivity in conventional sampling methods and unspecific symptoms in these patients, distinguishing between low-grade viral replication or hyperinflammation i...

Full description

Bibliographic Details
Main Authors: Nina Urke Ertesvåg, Sunniva Todnem Sakkestad, Fan Zhou, Ingrid Hoff, Trygve Kristiansen, Trygve Müller Jonassen, Elisabeth Follesø, Karl Albert Brokstad, Ruben Dyrhovden, Kristin G.-I. Mohn
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Viruses
Subjects:
SARS-CoV-2
monoclonal antibodies
antivirals
human long-term infection
low-grade viral replication
B cell immune responses
Online Access:https://www.mdpi.com/1999-4915/14/8/1757

Internet

https://www.mdpi.com/1999-4915/14/8/1757

Similar Items